200 related articles for article (PubMed ID: 33531640)
1. The Angelina Jolie effect: Contralateral risk-reducing mastectomy trends in patients at increased risk of breast cancer.
Basu NN; Hodson J; Chatterjee S; Gandhi A; Wisely J; Harvey J; Highton L; Murphy J; Barnes N; Johnson R; Barr L; Kirwan CC; Howell S; Baildam AD; Howell A; Evans DG
Sci Rep; 2021 Feb; 11(1):2847. PubMed ID: 33531640
[TBL] [Abstract][Full Text] [Related]
2. Risk-reducing mastectomy for the prevention of primary breast cancer.
Carbine NE; Lostumbo L; Wallace J; Ko H
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD002748. PubMed ID: 29620792
[TBL] [Abstract][Full Text] [Related]
3. Contralateral risk-reducing mastectomy in young breast cancer patients with and without genetic cancer risk assessment.
Mai PL; Lagos VI; Palomares MR; Weitzel JN
Ann Surg Oncol; 2008 Dec; 15(12):3415-21. PubMed ID: 18836779
[TBL] [Abstract][Full Text] [Related]
4. Timely cancer genetic counseling and testing for young women with breast cancer: impact on surgical decision-making for contralateral risk-reducing mastectomy.
Dettwyler SA; Thull DL; McAuliffe PF; Steiman JG; Johnson RR; Diego EJ; Mai PL
Breast Cancer Res Treat; 2022 Jul; 194(2):393-401. PubMed ID: 35596825
[TBL] [Abstract][Full Text] [Related]
5. Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer.
Evans DG; Ingham SL; Baildam A; Ross GL; Lalloo F; Buchan I; Howell A
Breast Cancer Res Treat; 2013 Jul; 140(1):135-42. PubMed ID: 23784379
[TBL] [Abstract][Full Text] [Related]
6. Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing.
Murphy BL; Yi M; Arun BK; Gutierrez Barrera AM; Bedrosian I
Ann Surg Oncol; 2020 Nov; 27(12):4613-4621. PubMed ID: 32720048
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Angelina Jolie (AJ)'s Story on Genetic Referral and Testing at an Academic Cancer Centre in Canada.
Raphael J; Verma S; Hewitt P; Eisen A
J Genet Couns; 2016 Dec; 25(6):1309-1316. PubMed ID: 27228984
[TBL] [Abstract][Full Text] [Related]
8. Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab).
Kiely BE; Jenkins MA; McKinley JM; Friedlander ML; Weideman P; Milne RL; McLachlan SA; Hopper JL; Phillips KA
Breast Cancer Res Treat; 2010 Apr; 120(3):715-23. PubMed ID: 19669874
[TBL] [Abstract][Full Text] [Related]
9. Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis.
Heemskerk-Gerritsen BA; Rookus MA; Aalfs CM; Ausems MG; Collée JM; Jansen L; Kets CM; Keymeulen KB; Koppert LB; Meijers-Heijboer HE; Mooij TM; Tollenaar RA; Vasen HF; ; Hooning MJ; Seynaeve C
Int J Cancer; 2015 Feb; 136(3):668-77. PubMed ID: 24947112
[TBL] [Abstract][Full Text] [Related]
10. Risk-reducing mastectomy rates in the US: a closer examination of the Angelina Jolie effect.
Liede A; Cai M; Crouter TF; Niepel D; Callaghan F; Evans DG
Breast Cancer Res Treat; 2018 Sep; 171(2):435-442. PubMed ID: 29808287
[TBL] [Abstract][Full Text] [Related]
11. Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the "Angelina Jolie Effect".
Staudigl C; Pfeiler G; Hrauda K; Renz R; Berger A; Lichtenschopf R; Singer CF; Tea MK
BMC Cancer; 2016 Jul; 16():436. PubMed ID: 27391110
[TBL] [Abstract][Full Text] [Related]
12. Feasibility study of contralateral risk-reducing mastectomy with breast reconstruction for breast cancer patients with BRCA mutations in Japan.
Yoshimura A; Okumura S; Sawaki M; Hattori M; Ishiguro J; Adachi Y; Kotani H; Gondo N; Kataoka A; Iwase M; Onishi S; Sugino K; Terada M; Horisawa N; Mori M; Takaiso N; Hyodo I; Iwata H
Breast Cancer; 2018 Sep; 25(5):539-546. PubMed ID: 29520501
[TBL] [Abstract][Full Text] [Related]
13. Global celebrities' effect on health awareness among Jordanians: A study using the case of Angelina Jolie.
Al-Hussaini M; Ammar K; Kasasbeh N; Sultan H; Al-Omari A
J Genet Couns; 2019 Oct; 28(5):1021-1028. PubMed ID: 31386265
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the effect of the American Society of Breast Surgery guidelines on contralateral prophylactic mastectomy rates for unilateral breast cancer.
Steadman JA; Hoskin TL; Klassen C; Boughey JC; Degnim AC; Piltin MA; Mrdutt MM; Johnson JE; Hieken TJ
Surgery; 2024 Mar; 175(3):677-686. PubMed ID: 37863697
[TBL] [Abstract][Full Text] [Related]
15. The Angelina effect: immediate reach, grasp, and impact of going public.
Borzekowski DL; Guan Y; Smith KC; Erby LH; Roter DL
Genet Med; 2014 Jul; 16(7):516-21. PubMed ID: 24357847
[TBL] [Abstract][Full Text] [Related]
16. The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services.
Evans DG; Barwell J; Eccles DM; Collins A; Izatt L; Jacobs C; Donaldson A; Brady AF; Cuthbert A; Harrison R; Thomas S; Howell A; ; ; Miedzybrodzka Z; Murray A
Breast Cancer Res; 2014 Sep; 16(5):442. PubMed ID: 25510853
[TBL] [Abstract][Full Text] [Related]
17. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
Clin Breast Cancer; 2018 Apr; 18(2):e205-e218. PubMed ID: 29050918
[TBL] [Abstract][Full Text] [Related]
18. Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations: A Multi-institutional Study.
Jakub JW; Peled AW; Gray RJ; Greenup RA; Kiluk JV; Sacchini V; McLaughlin SA; Tchou JC; Vierkant RA; Degnim AC; Willey S
JAMA Surg; 2018 Feb; 153(2):123-129. PubMed ID: 28903167
[TBL] [Abstract][Full Text] [Related]
19. Celebrity Health Announcements and Online Health Information Seeking: An Analysis of Angelina Jolie's Preventative Health Decision.
Dean M
Health Commun; 2016; 31(6):752-61. PubMed ID: 26574936
[TBL] [Abstract][Full Text] [Related]
20. Trends in Contralateral Prophylactic Mastectomy Utilization for Small Unilateral Breast Cancer.
Baskin AS; Wang T; Bredbeck BC; Sinco BR; Berlin NL; Dossett LA
J Surg Res; 2021 Jun; 262():71-84. PubMed ID: 33548676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
